Physician profile
Darin Scribner
NPI 1154717585
$11,193.07
in general payments reported to CMS, 2019-2025
10 companies · $9,801 in 2025
The $9,801 reported for 2025 was more than what 97% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $718 · 2021: $245 · 2022: $150 · 2023: $119 · 2024: $161 · 2025: $9,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,610 · Travel and Lodging: $3,795 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,610.00 |
| Travel and Lodging | $3,794.57 |
| Food and Beverage | $675.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $9,862.18 | 2021-2025 | Sprint Pns System |
| Boston Scientific Corporation | $828.54 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Relievant Medsystems, INC. | $130.66 | 2021 | |
| Medtronic, INC. | $122.43 | 2022-2023 | Intellis Adaptivestim |
| Abbvie INC. | $103.50 | 2022-2024 | Botox |
| Stimwave Technologies Incorporated | $69.00 | 2021 | |
| Abbott Laboratories | $28.95 | 2020-2023 | Ionicrf |
| Averitas Pharma INC. | $17.69 | 2024 | Qutenza |
| Medtronic USA, INC. | $15.09 | 2020 | |
| Allergan, INC. | $15.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Scribner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.